The way property values are displayed:
The way concept relations are shown:
The way concept relations are shown:
Immunoproliferative Small Intestinal Disease
Hierarchy: | ∟ ∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease 28 coordinate concepts∟ ∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease 28 coordinate concepts∟ ∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease 28 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease 28 coordinate concepts∟ ∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease 28 coordinate concepts∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease 28 coordinate concepts∟ ∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease 28 coordinate concepts∟ ∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease 28 coordinate concepts∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease 28 coordinate concepts∟ ∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease 28 coordinate concepts∟ ∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease 28 coordinate concepts∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease 28 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease 28 coordinate conceptsX |
Broader terms: | ∟ ∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease ∟ ∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease ∟ ∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease ∟ ∟ ∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease ∟ ∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease ∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease ∟ ∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease ∟ ∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease ∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease ∟ ∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease ∟ ∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease ∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease ∟ ∟ ∟ ∟ ∟ ∟ Immunoproliferative Small Intestinal Disease |
History note: | |
historyNote*: | 87
X |
publicMeSHNote*: | 87
X |
Scope note: | A condition that is caused by HYPERPLASIA of LYMPHOCYTES in the small intestine (INTESTINE, SMALL) and the mesenteric LYMPH NODES. These lymphocytes produce an anomalous alpha heavy chain protein. Generally, these IPSID patients have either concurrent LYMPHOMA or develop lymphoma within a few years. The disease was first described in the Mediterranean region and is characterized by malabsorption; WEIGHT LOSS; DIARRHEA; and STEATORRHEA.
X |
activeMeSHYear*: | |
dateCreated*: | 1986-06-24X |
dateEstablished*: | 1987-01-01X |
dateRevised*: | 2005-06-30X |
recordAuthorizer*: | sjnX |
recordMaintainer*: | lktX |
recordOriginator*: | VDKX |
Type: | |
Coordinate terms: | |
URI: | |
Labels and equivalent concepts: | Immunoproliferatiivinen ohutsuolisairaus (fi) XVälimeren lymfooma (fi, replaced) Immunoproliferatiivinen ohutsuolen tauti (fi, replaced) Lymphoma, Mediterranean (en, replaced) Heavy Chain Disease, IgA Type (en, replaced) IPSID (en, replaced) alpha-Chain Disease (en, replaced) Lymphoma mediterraneum (la-FI, replaced) Morbus intestini tenuis immunoproliferativus (la-FI, replaced) |
Share: |
Loading results...